{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:41:04Z","timestamp":1759459264231,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1053\/j.ajkd.2013.06.018","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T03:59:59Z","timestamp":1374811199000},"page":"844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Minimal Change Disease and Lenalidomide"],"prefix":"10.1053","volume":"62","author":[{"given":"Matthieu","family":"Jamme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Galichon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Hertig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2013.06.018_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0272-6386(89)80130-1","article-title":"Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs","volume":"13","author":"Warren","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2013.06.018_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000184075","article-title":"Waldenstr\u00f6m macroglobulinemia and nephrotic syndrome with minimal change lesion","volume":"45","author":"Hory","year":"1987","journal-title":"Nephron"},{"issue":"11","key":"10.1053\/j.ajkd.2013.06.018_bib3","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1093\/ndt\/gfl467","article-title":"Serum monoclonal component and nephrotic syndrome\u2014it is not always amyloidosis","volume":"21","author":"Terrier","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2013.06.018_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00277-012-1586-z","article-title":"Steroid-resistant minimal change nephrotic syndrome in Waldenstr\u00f6m macroglobulinemia","volume":"92","author":"Sayegh","year":"2013","journal-title":"Ann Hematol"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2013.06.018_bib5","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0268-960X(10)70004-7","article-title":"Lenalidomide mode of action: linking bench and clinical findings","volume":"24","author":"Davies","year":"2010","journal-title":"Blood Rev"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861301010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861301010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:15:13Z","timestamp":1759457713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263861301010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S027263861301010X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.06.018","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal Change Disease and Lenalidomide","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}